While Russia is one of the top producers of both metals, it is not the only source of these metals so it should be fine.
Clinical trial supply especially in Phase 1 and 2 where Clarity's products are in will not need an extensive supply so it shouldn't be a big issue.
- Forums
- ASX - By Stock
- CU6
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-6
Featured News
Add CU6 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.86 |
Change
-0.430(5.90%) |
Mkt cap ! $2.163B |
Open | High | Low | Value | Volume |
$7.25 | $7.35 | $6.85 | $7.784M | 1.108M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 10173 | $6.86 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.96 | 3202 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 10173 | 6.860 |
6 | 27090 | 6.850 |
2 | 12951 | 6.840 |
1 | 6351 | 6.820 |
1 | 292 | 6.810 |
Price($) | Vol. | No. |
---|---|---|
6.960 | 3202 | 2 |
6.980 | 25277 | 2 |
7.000 | 6851 | 2 |
7.020 | 6351 | 2 |
7.040 | 6351 | 1 |
Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |